» Articles » PMID: 21705225

Convolutamines I and J, Antitrypanosomal Alkaloids from the Bryozoan Amathia Tortusa

Overview
Journal Bioorg Med Chem
Specialties Biochemistry
Chemistry
Date 2011 Jun 28
PMID 21705225
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Mass-directed isolation of the CH(2)Cl(2)/CH(3)OH extract from the marine bryozoan Amathia tortusa resulted in the purification of two new brominated alkaloids, convolutamines I (1) and J (2). The structures of 1 and 2 were determined following spectroscopic data analysis. Both compounds were isolated during a drug discovery program aimed at identifying new antitrypanosomal leads from a prefractionated natural product library. Compounds 1 and 2 were shown to be active toward the parasite Trypanosoma brucei brucei with IC(50) values of 1.1 and 13.7 μM, respectively. Preliminary toxicity profiling was also performed on both 1 and 2 using the human embryonic kidney cell line, HEK293. Compound 1 was shown to exhibit cytotoxicity against HEK293 with an IC(50) of 22.0 μM whilst 2 was inactive at 41.0 μM.

Citing Articles

Marine Natural Products as Novel Treatments for Parasitic Diseases.

Cheng W, Huang Y, Gao H, Bold B, Zhang T, Yang D Handb Exp Pharmacol. 2024; 287():325-393.

PMID: 38554166 DOI: 10.1007/164_2024_712.


Naturally Occurring Organohalogen Compounds-A Comprehensive Review.

Gribble G Prog Chem Org Nat Prod. 2023; 121:1-546.

PMID: 37488466 DOI: 10.1007/978-3-031-26629-4_1.


Marine alkaloids as bioactive agents against protozoal neglected tropical diseases and malaria.

Tempone A, Pieper P, Borborema S, Thevenard F, Lago J, Croft S Nat Prod Rep. 2021; 38(12):2214-2235.

PMID: 34913053 PMC: 8672869. DOI: 10.1039/d0np00078g.


The Phylum Bryozoa: From Biology to Biomedical Potential.

Ciavatta M, Lefranc F, Vieira L, Kiss R, Carbone M, van Otterlo W Mar Drugs. 2020; 18(4).

PMID: 32283669 PMC: 7230173. DOI: 10.3390/md18040200.


Current Screening Methodologies in Drug Discovery for Selected Human Diseases.

Lage O, Ramos M, Calisto R, Almeida E, Vasconcelos V, Vicente F Mar Drugs. 2018; 16(8).

PMID: 30110923 PMC: 6117650. DOI: 10.3390/md16080279.